Split-Dose R-CHOP for Older Patients with Treatment Naive DLBCL

被引：0
|
作者：
Kidwell, Adam [1 ]
Furqan, Fateeha [2 ]
Aschenbrenner, Emilie [3 ]
Longo, Walter [4 ]
Devata, Sumana [3 ]
Hamadani, Mehdi [5 ]
Fenske, Timothy S. [2 ]
Shah, Nirav N. [6 ]
机构：
[1] Froedtert Hosp, Med Coll Wisconsin, Canc Ctr, Milwaukee, WI USA
[2] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[3] Med Coll Wisconsin, Milwakee, WI USA
[4] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[5] Med Coll Wisconsin Inc, Div Hematol & Oncol, Milwaukee, WI USA
[6] Froedtert Hosp, Med Coll Wisconsin, Canc Ctr, Brookfield, WI USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203974
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2374 / 2375
页数：2
相关论文
共 50 条
  • [41] Bcl-6 protein not a prognostic indicator in patients with DLBCL receiving R-CHOP therapy
    Nature Clinical Practice Oncology, 2006, 3 (8): : 413 - 413
  • [42] Routine Prophylaxis of Pneumocystis Pneumonia from the Fourth Cycle of R-CHOP Regimen in DLBCL Patients
    Park, Silvia
    Kim, Seok Jin
    Kim, Won Seog
    BLOOD, 2017, 130
  • [43] Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2
    Sehn, Laurie
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S440 - S440
  • [44] Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Bantilan, Kurt S.
    Smith, Alexandra N.
    Maurer, Matthew J.
    Teruya-Feldstein, Julie
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Straus, David J.
    Noy, Ariela
    Palomba, M. Lia
    Horwitz, Steven M.
    Hamlin, Paul A.
    Portlock, Carol S.
    Cerhan, James R.
    Habermann, Thomas M.
    Salles, Gilles A.
    Nowakowski, Grzegorz S.
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    BLOOD ADVANCES, 2024, 8 (09) : 2172 - 2181
  • [45] Phase 3 trial of subcutaneous epcoritamab plus R-CHOP versus R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2.
    Sehn, Laurie Helen
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew John John
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery
    Wilson, Matthew R.
    Eyre, Toby A.
    Martinez-Calle, Nicolas
    Ahearne, Matthew
    Parsons, Katrina E.
    Preston, Gavin
    Khwaja, Jahanzaib
    Schofield, Jeremy
    Elliot, Johnathon
    Mula, Almurtadha Kh
    Shah, Nimish
    Cheung, Cheuk-Kie
    Timmins, Matthew A.
    Creasey, Thomas
    Linton, Kim
    Smith, Jeffery
    Fox, Christopher P.
    Miall, Fiona
    Cwynarski, Kate
    McKay, Pamela
    BLOOD ADVANCES, 2020, 4 (15) : 3586 - 3593
  • [47] Prognostic indices in older DLBCL patients receiving R-CHOP: An analysis of the US intergroup study (E4494, CALGB 9793).
    Advani, R. H.
    Chen, H.
    Habermann, T. M.
    Morrison, V. A.
    Weller, E.
    Fisher, R. I.
    Peterson, B. A.
    Gascoyne, R. D.
    Horning, S. J.
    BLOOD, 2006, 108 (11) : 244A - 244A
  • [48] Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement
    Geng, Hongzhi
    Jia, Sixun
    Zhang, Ying
    Li, Jiaqi
    Yang, Qin
    Zeng, Liangyu
    Zong, Xiangping
    Lu, Yutong
    Lu, Shuangzhu
    Zhou, Jin
    Li, Caixia
    Wu, Depei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] An immunocompetent, spontaneous mouse model of DLBCL for studying the response to R-CHOP and identifying new treatment targets
    Maybury, B.
    Fitzgibbon, J.
    Calado, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 110 - 111
  • [50] Characterising Tumour and Microenvironmental Responses to R-CHOP in Immunocompetent Mouse Models of DLBCL
    Maybury, Bernard D.
    Bewicke-Copley, Findlay
    Peter, Johnson
    Fitzgibbon, Jude
    Calado, Dinis Pedro
    BLOOD, 2021, 138
12345